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Studies involving endocrine effects in humans and experimental animals resulting from the exposure to dioxin-like (non-ortho-substituted PCBs,
PCDDs/PCDFs) and nondioxin-like (PCBs, OC pesticides) compounds (DLCs and NDLCs) were presented. A variety of reproductive and hormonal
parameters, including androgen status, sexual differentiation, and thyroid functionality, were discussed. As in utero and lactational exposure of the
human fetus/neonate to these environmental contaminants is inevitable, continued research to identify sensitive biomarkers of effect and suscepti-
bility, as well as to define dose-response relationships, is required. - Environ Health Perspect 103(Suppl 2):147-150 (1995)
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Introduction
In opening remarks, Dr. Dewailly stated
that the endocrine session would present
data from experimental studies on the
effects of dioxin-like compounds (DLCs)
on sex hormone and thyroid functions, and
indicate ways in which this information is
applied in the development of biomarkers
ofeffects or susceptibility for use in human
epidemiologic studies.
Two questions were raised concerning
the development ofendocrine biomarkers:
* Are changes in thyroid function respon-
sible for the neurobehavioral effects that
are observed in experimental animals/
humans?
* In the development of endocrine bio-
markers from animal data, which ofthe
species differences (rodents vs humans)
are significant (e.g., differences in thy-
roid histology; and lack of thyroid-
binding globulin, shorter T1/2 for thy-
roxine and increased serum TSH levels
in rodents)?
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Animal Studies
Dioxin and dioxin-like compounds
(DLCs) have been shown to cause overt
toxicity in the male reproductive system of
experimental animals. Recent studies of
occupational cohorts exposed to TCDD
suggest that some of the adverse effects of
TCDD that are observed in rodents
(reduced libido, decreased testicular size,
gonadotropin/androgen alterations) may
occur in humans.
Dr. Moore described the effects ofperi-
natal exposures to TCDD on the sexual
differentiation of male rats. For a pheno-
typic male to develop from a genotypic
male, sufficient testosterone (Ts) must be
secreted by the fetal testes at the appropri-
ate time. The proper Ts profile permits sex
organs to mature normally and for patterns
ofmale sexual behavior to be imprinted. If
the Ts profile for male development is
altered, the default phenotype, female, is
expressed.
In previous studies (1-3), TCDD
when administered to pregnant female rats
(single oral dose of 0.064-1.00 pg/kg on
gestational day 15) affected a variety of
androgenic status indices [spermatogenesis,
adult sexual behavior, luteinizing hormone
(LH) secretion pattern] in the male off-
spring in a dose-dependent manner. This
maternal TCDD exposure also reduced in
male offspring the prebirth plasma Ts levels
and the postparturition surge ofTs.
In follow-up experiments, male off-
spring ofTCDD-dosed females (single 0.7
pg/kg oral dose on gestational day 15) were
castrated on day 63 (postpuberty) and
implanted with Ts-containing silastic cap-
sules to maintain physiological levels of
serum Ts (2 ng/ml). These male offspring
ofTCDD-treated dams had reductions in
whatwould normally be Ts-inducedweight
gains in theventral prostate. The reductions
were not due to decreases in either cell
numbers or levels ofTs or dihydro-Ts in
the ventral prostate, or to changes in Kd or
B. values for androgen receptors. Weights
ofseminal vesicles were also decreased in a
dose-dependent manner in these male off-
spring ofTCDD-treated dams. In contrast
to the ventral prostate, no TCDD effect
was seen in castrated or implanted males in
wet weight gain, protein and DNA content
or amount ofTs or dihydro-Ts in seminal
vesicles.
Male offspring from TCDD-treated
dams also had dose-dependent alterations
in sexual behaviour (demasculinization,
feminization, feminized pattern of LH
secretion). Sexual differentiation in the
central nervous system of male rats is
dependent upon levels of 170-estradiol
(related to perinatal Ts). TCDD has been
shown to alter Ts levels in male offspring.
To investigate whether it altered estradiol
as well, experiments were conducted to dis-
cern effects of TCDD on sexual dimor-
phism. Perinatal exposures to TCDD did
not alter the volumes of medial preoptic
nuclei or the distribution patterns ofestro-
gen receptors in the brain, two features of
sexual dimorphisms in rats.
Spermatogenesis in rats was sensitive to
prenatal exposures to TCDD: reductions
in daily sperm production and sperm
counts in the caudal epididymis continued
to occur in the sexually mature (day 120)
male offspring of dams treated with
TCDD at dose levels as low as 64 ng/kg
(gavage on gestational day 15). Flow cyto-
metric methods were used to investigate
Sertoli cell division but revealed no effects
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of TCDD on Sertoli cell labeling index
(LI) at parturition or on ploidy levels in
the testes. Future experiments are planned
to examine the Sertoli cell LI at prepartu-
rition and in the adult, to undertake quan-
titative testes morphology.
Dr. Schantz reviewed her published
studies on the effects ofperinatal exposures
on thyroid function. Exposures of adult
animals to PCB mixtures (Aroclor 1254)
increased the metabolism of thyroxine
(T4); decreased the serum levels ofthyroid
hormones [TH, T3 (triiodothyronine) and
T4]; diminished the response ofserum TH
levels to exogenous thyroid stimulating
hormone (TSH) as well as the binding of
congeners and/or metabolites to the main
rat TH-transport protein (transthyretin);
and had indirect/direct toxic effects on the
thyroid gland.
In a study initially designed to investi-
gate the behavioral effects associated with
perinatal exposure to individual PCB con-
geners in rats, offspring TH status and thy-
roid gland histology were investigated (4).
Three PCB congeners were selected,
IUPAC Nos. 28, 118 and 153 (2,4,4';
2,3',4,4',5; 2,2',4,4',5,5', respectively) on
the basis of their environmental and
human occurrence and suspected effect on
brain catecholamine function. These three
congeners had been previously shown to
comprise up to 25% ofthe total PCB con-
tent ofhuman breast milksamples (5).
Doses of the congeners, preselected to
minimize developmental toxicity, were
administered to SD rats on gestational days
10 to 16 by gavage. At weaning (day 21
postparturition), samples were collected for
serum TH analysis and thyroid histology.
None of the reproductive parameters
measured (litter size, percent live births,
pup survival to weaning, dam weight gain,
or liver weights) were affected by the
PCBs. Pups in the high-dose congener 118
group (16 mg/kg/day), however, exhibited
significantly reduced body weights (25%)
in both sexes up to weaning. In the case of
the male pups, this effect was still evident
by day 90. Pup serum T4 levels in both
sexes were unaffected by congener 28,
reduced approximately 50% in the high
dose group of congener 153 (64 mg/kg/
day), and drastically decreased in the high
dose group ofcongener 118 (approximately
90%). Pup T3 levels, as well as dam TH
levels, were not affected.
Thyroid gland histology in thehigh dose
congener 118 pups revealed an increase in
the height ofepithelial cells, a reduction in
the colloid area and an increase in follicular
cell cytoplasm vacuolation and amount of
nuclear vesiculation. These effects are con-
sistent with sustained TSH stimulation of
the thyroid in response to low circulating
levels ofT4.
In a similar study involving non-ortho-
substituted PCB congeners 77 and 169
(6), both maternal TT4 (total T4) and
fetal FT4 (free T4) in Wistar rats were
reduced by a single dose ofPCB congener
169 (3,3',4,4',5,5') (1.8 mg/kg) on day 1
of gestation. In addition, neonatal TT4
levels were decreased in a group in which
dams were exposed to PCB congener 169
(0.6 mg/kg) on gestational day 1 and PCB
congener 77 (3,3',4,4') (1 mg/kg) on days
2 to 19. The observed consequences ofthe
decreased fetal plasma T4 included
increased brain type II 5'-deiodinase activi-
ty. One possible mechanism for the reduc-
tion of plasma T4 is the displacement of
T4 from transthyretin by hydroxylated
PCB metabolites, enhancing T4 metabo-
lism. In a subsequent study, the induction
of hepatic T4-UDPGT (uridine 5'-
diphosphate (UDP)-glucuronyltransferase)
activity by PCB congener 169 is described
as the probable cause of decreased neona-
tal and maternal, but not fetal, plasma
TT4 levels (7).
Thyroid hormone levels are critical for
brain development in the rat, and the
majority offetal and neonatal brain T3 in
the rat is derived from serum T4. Future
experiments will examine whether neona-
tal hypothyroidism affects neurobehav-
ioral development. In addition, T4
replacement studies are planned, since
neonatal hypothyroid states decrease the
dendritic branching pattern among hip-
pocampal neurons.
Physiology oftheThyroid
Dr. Rhainds reviewed the role of thyroid
hormones in human fetal development,
describing physiology of the thyroid,
changes in thyroid hormone levels during
pre- and postnatal development, and clini-
cal thyroid function tests.
Figure 1 summarizes the synthesis,
release, binding, and transport in serum,
metabolism, and regulation by the hypo-
thalamic-pituitary-thyroid axis (HPT) of
thyroid hormones.
Proteolytic degradation ofthyroglobulin
in the thyroid results in the release ofTH.
In the blood, the majority ofTH is bound
to TBG (80%), with lesser quantities
bound to TBP and albumin. TH are
metabolized by three isozymes of5'-mono-
deiodinases (classified on the basis ofpropy-
Ithiouracil sensitivity). Preferential conver-
sion ofT4, considered a prehormone, to
the active T3 in peripheral tissues occurs
primarily through type II 5'-monodeiodi-
nase activity. Type I 5'-monodeiodinase
activity functions in rodents, and possibly
humans, to provide T3 to the plasma (8).
Thyroid hormone-responsive tissues con-
tain nuclear receptors with high binding
affinity for T3 (90% ofreceptors are bound
with T3). Regulation ofgene expression by
thyroid hormones requires their interaction
with thyroid hormone nuclear receptors,
and T3 levels are, therefore, important for
maintaining the normal euthyroid state (9).
The relationship between maternal and
fetal levels of TSH, TBG, free and total
T4 (FT4, TT4), and T3 has not been
established (10). Maternal transfer ofTH
to the neonate does not occur in physio-
logically significant amounts, due in part
to 5'-deiodinase activity in the placenta. In
addition, the placenta is impermeable to
maternal TSH.
It is thought that production ofT4 by
the fetal thyroid gland is delayed until 10
to 12 weeks ofgestation, and is followed at
18 to 22 weeks by an abrupt increase in the
level offetal serum TSH. At week 25, levels
ofTSH plateau until birth. At birth, they
can surge upwards due to severing of the
umbilical cord and cooling ofthe neonate.
The increase in the neonatal free T4/TSH
ratio after birth is due primarily to the
decrease in serum TSH levels.
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Figure 1. TSH synthesis and secretion by the anterior
pituitary is under feedback control by both TRH pro-
duced in the hypothalamus and the level of circulating
thyroid hormones (T3, T4). TSH activates both
increased iodide uptake and thyroglobulin hydrolysis in
the thyroid, resulting in the release of thyroid hor-
mones. Thyroid hormones in the circulation are bound
primarily to TBG fortransportto peripheral tissues. The
liver is the major site of thyroid hormone degradation
via Phase 11 conjugation reactions and excretion into
the bile. TSH, thyroid stimulating hormone (thy-
rothropin); TRH, thyrotropin releasing hormone; T3,
3,5,3'-triiodothyronine; T4, 3,5,3',5'-tetraiodothyronine
(thyroxine); TBG,thyroxine binding globulin.
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Fetal serum total T4, free T4, and TBG
values reach adult levels by week 36 ofges-
tation, and reflect the continuing matura-
tion process ofthe HPT axis and the liver.
Infant TBG levels at birth are usually 1.5-
fold higher than maternal values and
remain elevated for up to the first 3 years.
Free and total T3 values in fetal serum
are low by 30 to 32 weeks ofgestation but
then gradually increase until parturition. At
birth, T3 levels remain lower than the
adult, due to incomplete development of
T4 conversion processes in peripheral tis-
sue. The maturation ofthe neonatal hypo-
thalamus-pituitary control of TSH secre-
tion is generally not complete until 1 to 2
months postpartum.
The determination of thyroid status
can be made by quantification of blood
levels of TSH, TBG, and free and total
TH by radioimmunoassay (RIA) tech-
niques. Free TH levels can also be mea-
sured by dialysis and by mathematical
derivation using data from total T4 and
T3 estimations. Thyroid functionality can
be assessed by 131I uptake, TRH stimula-
tion ofthe pituitary gland, and subsequent
TSH secretion. The degree ofsaturation of
TBG can be estimated by the resin T3
uptake test. The total concentration of
serum TBG can be estimated by combin-
ing the results with total T4 levels. Various
factors that can influence levels of TH,
TSH, and TBG include a) serum TBG
concentrations and available binding sites,
which will influence T4 values; b) brain
androgen deprivation, which has a sup-
pressive effect on TSH secretion; c) levels
of estrogen and androgen, which increase
and decrease, respectively, serum TBG val-
ues as well as basal and TRH- stimulated
TSH levels; d) dopamine levels, which
decrease the basal and TRH-stimulated
TSH levels; and e) induction of hepatic
enzymes (UDPGT), which increase the
excretion ofconjugated T4 into the bile.
Human Studies
Dr. Koopman-Esseboom reviewed an
ongoing study comparing endocrine effects
from perinatal exposures to low levels of
DLCs in 200 Dutch children (100 breast
fed, 100 formula fed). Infant (10 days and
3 months postpartum), maternal, and
umbilical cord blood samples were
obtained and analyzed for T3, T4, TSH,
and FT4. Results were compared to breast
milk levels of dioxins, coplanar PCBs and
other PCB congeners (milk samples col-
lected 10 days after birth, 24-hr collection).
The neonatal TSH levels were elevated
at 10 days and 3 months. There was no
effect on T4. The increased TSH levels
were related to increased breast milk dioxin
and coplanar PCB values. There was no
correlation of levels of thyroid hormones
with breast milk concentrations of PCB
congeners 118, 138, 153, and 180.
Previous results (11) had revealed no sig-
nificant association between infant growth
parameters (height, weight, cranial cir-
cumference) and breast milk PCB levels. A
battery of infant neurobehavioral tests are
also planned.
In a similar study (12), breast milk
TCDD TEQ (PCDDs/PCDFs) values of
37.5 ng/kg milk fat (high exposure group)
were associated with elevated levels of
neonatal TT4 and TT4/TBG at 1 and 11
weeks post partum. TSH levels were also
increased in the neonates but only at 11
weeks ofage.
All comparisons were made with the
"low" exposure group, exposed to breast
milk with TCDD TEQ levels of 18.6
ng/kg milk fat.
Dr. Rogan reported on the status offol-
low-up studies on the infant cohort from
the North Carolina Breast Milk and
Formula Project, which was initiated in
1978. The children are now 11 to 15 years
old. They have been sent (1/1/93) pictorial
representations of sexual development
indices (Tanner Scale) and asked to per-
form aself-assessment, including pre-puber-
tal height and weight. All girls involved in
the project are at Tanner Scale 2 and will
continue to be assessed post-puberty.
One of the findings reported in the
original study (13) was that breast milk
DDE (dichlorodiphenyl dichloroethene)
concentrations and duration of lactation
seemed to be inversely correlated: women
with the lowest 5% of breast milk DDE
levels (<1.99 mg/kg milk fat) lactated on
average for 26 weeks, while women with
the upper 5% of DDE breast milk levels
(>6.00 mg/kg milk fat) lactated for only 10
weeks. This relationship suggests that o,p'-
DDE may act as an "environmental estro-
gen" and antagonize prolactin effects.
In a preliminary investigation to further
explore this hypothesis (14), Dr. Rogan
compared the breast milk DDE levels with
the duration of lactation among 229
women from a region of Mexico where
agricultural use ofDDT is heavy. Mothers
with breast milk DDE concentrations of0
to 2.5 mg/kg milk fat breast fed an average
of 7.5 months, while women with breast
milk DDE concentrations of greater than
7.5 mg/kg milk fat breast fed for approxi-
mately 3.4 months.
Dr. Dewailly reported on several epi-
demiologic studies his group is undertak-
ing. A cord blood study compared serum
TSH levels (routine screening for
hypothyroidism) among Inuit children
with their exposures to contaminants in
breast milk. No association was found
between TSH and contaminant levels.
Birth length of males, however, did show
a statistically significant negative correla-
tion with breast milk PCB congeners
(IUPAC Nos. 118, 138, 153, 170, 180,
183, 187). In contrast, The birth length
of females was positively associated with
breast milk TCDD TEQs (coplanar
PCBs, PCDDs/PCDFs) (15).
As part of the Arctic Monitoring and
Assessment Program (AMAP), cord blood
samples in future Inuit health surveys will
be collected from birthing centers in the
Northwest Territories, northern Labrador,
and Quebec and analyzed for essential trace
elements (Se, Cu, Zn), omega-3 fatty acids,
and food chain contaminants [OC pesti-
cides, PCB congeners, PCDDs/PCDFs,
and toxic metals (Cd, Pb, Hg)]. Dr. Ayotte
described a number of biomarkers for
effect/susceptibility thatwill be investigated
in this study. The control population will
be obtained from southern Quebec. An
additional cord blood study, which is simi-
lar to the AMAP study, will be undertaken
using births to families ofcommercial fish-
ermen of the Lower North Shore St.
Lawrence River.
Conclusions
In experimental animals, perinatal exposure
to dioxin- and non-dioxin-like compounds
is capable of causing endocrine-related
effects in offspring in the absence of overt
signs ofmaternal toxicity. Consequences of
this "maternal" exposure include: deficits
in androgen-dependent differentiation
(imprinting) and neurologic development
in rodents; and alterations in thyroid
homeostasis in rodents. These effects may
be interrelated. Epidemiologic investiga-
tions indicate that exposure to contami-
nants in utero or via lactation may be asso-
ciated with impairment of physical and
neurologic development in the fetus/
neonate. Future epidemiologic studies that
use biomarkers in cooperation with data
from animal studies can provide useful
information for developing strategies for
prevention and regulation.
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